Inao, Judylyn B.
HRN: 23-08-99 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
06/10/2025
CEFUROXIME 1.5GM (VIAL)
06/10/2025
06/12/2025
IVT
15g
Q8
Sp TAHBSO
Waiting Final Action
Indication: Empiric Type of Infection: Reproductive Tract Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes